Management of concomitant coronary artery disease and aortic valve stenosis in the era of transcatheter aortic valve treatment

Abstract

Severe calcific aortic stenosis (AS) and coronary artery disease (CAD) have common risk factors and are frequently encountered in the same patient in clinical practice. CAD has been reported in ≥ 50% of AS patients undergoing both surgical treatment and transcatheter aortic valve implantation (TAVI). In the last two decades, TAVI has been established as a less invasive alternative to surgery. Recently, more and more young and low surgical risk patients undergo TAVI. Despite the high prevalence of CAD in patients treated with TAVI, the management strategy of concomitant CAD in these patients remains an area of considerable uncertainty. This review provides an updated overview of the current knowledge about this topic and offers points for reflection about the best approach to use.

Keywords

Severe aortic stenosis / coronary artery disease / transcatheter aortic valve implantation

References

[1] Iung B,Rosenhek R.EORP VHD II InvestigatorsContemporary presentation and management of valvular heart disease: the Eurobservational research programme valvular heart disease II survey.Circulation2019;140:1156-69

[2] Stewart B,Lind BK.Clinical factors associated with calcific aortic valve disease fn1fn1.J Am Coll Cardiol1997;29:630-4

[3] Yan AT,Chan KK.Association between cardiovascular risk factors and aortic stenosis: the CANHEART aortic stenosis study.J Am Coll Cardiol2017;69:1523-32

[4] Iung B.Interface between valve disease and ischaemic heart disease.Heart2000;84:347-52 PMCID:PMC1760937

[5] Auffret V,Van Belle E.FRANCE TAVI InvestigatorsTemporal trends in transcatheter aortic valve replacement in France: France 2 to France TAVI.J Am Coll Cardiol2017;70:42-55

[6] Makkar RR,Jilaihawi H.PARTNER Trial InvestigatorsTranscatheter aortic-valve replacement for inoperable severe aortic stenosis.N Engl J Med2012;366:1696-704

[7] Kodali SK,Smith CR.PARTNER Trial InvestigatorsTwo-year outcomes after transcatheter or surgical aortic-valve replacement.N Engl J Med2012;366:1686-95

[8] Reardon MJ,Popma JJ.SURTAVI InvestigatorsSurgical or transcatheter aortic-valve replacement in intermediate-risk patients.N Engl J Med2017;376:1321-31

[9] Leon MB,Mack MJ.PARTNER 2 InvestigatorsTranscatheter or surgical aortic-valve replacement in intermediate-risk patients.N Engl J Med2016;374:1609-20

[10] Mack MJ,Thourani VH.PARTNER 3 InvestigatorsTranscatheter aortic-valve replacement with a balloon-expandable valve in low-risk patients.N Engl J Med2019;380:1695-705

[11] Popma JJ,Yakubov SJ.Evolut Low Risk Trial InvestigatorsTranscatheter aortic-valve replacement with a self-expanding valve in low-risk patients.N Engl J Med2019;380:1706-15

[12] Saia F,Compagnone M.Coronary artery disease and reasonably incomplete coronary revascularization in high-risk patients undergoing transcatheter aortic valve implantation.Catheter Cardiovasc Interv2020;95:19-27

[13] Witberg G,Chen S.The prognostic effects of coronary disease severity and completeness of revascularization on mortality in patients undergoing transcatheter aortic valve replacement.JACC Cardiovasc Interv2017;10:1428-35

[14] Kleczynski P,Bagienski M.Impact of coronary artery disease burden on 12-month mortality of patients after transcatheter aortic valve implantation.J Interv Cardiol2016;29:375-81

[15] Kotronias RA,George S.Transcatheter aortic valve implantation with or without percutaneous coronary artery revascularization strategy: a systematic review and meta-analysis.J Am Heart Assoc2017;6:e005960 PMCID:PMC5669191

[16] Witberg G,Codner P,Kornowski R.Impact of coronary artery revascularization completeness on outcomes of patients with coronary artery disease undergoing transcatheter aortic valve replacement: a meta-analysis of studies using the residual SYNTAX score (Synergy Between PCI With Taxus and Cardiac Surgery).Circ Cardiovasc Interv2018;11:e006000

[17] D'Ascenzo F,Visconti M.Independent impact of extent of coronary artery disease and percutaneous revascularisation on 30-day and one-year mortality after TAVI: a meta-analysis of adjusted observational results.EuroIntervention2018;14:e1169-77

[18] Tjang YS,Körfer R,van der Heijden GJ.Predictors of mortality after aortic valve replacement.Eur J Cardiothorac Surg2007;32:469-74

[19] Fujita B,Bauer T.GARY Executive BoardTrends in practice and outcomes from 2011 to 2015 for surgical aortic valve replacement: an update from the German Aortic Valve Registry on 42776 patients.Eur J Cardiothorac Surg2018;53:552-9

[20] Vahanian A,Praz F.ESC/EACTS Scientific Document Group, ESC Scientific Document Group2021 ESC/EACTS Guidelines for the management of valvular heart disease.Eur Heart J2021:ehab395

[21] Otto CM,Bonow RO.Writing Committee Members2020 ACC/AHA Guideline for the management of patients with valvular heart disease: executive summary: a report of the American college of Cardiology/American Heart Association Joint Committee on clinical practice guidelines.J Am Coll Cardiol2021;77:450-500

[22] Khawaja MZ,Pocock S,Thomas MR.The percutaneous coronary intervention prior to transcatheter aortic valve implantation (ACTIVATION) trial: study protocol for a randomized controlled trial.Trials2014;15:300 PMCID:PMC4132914

[23] Patterson T,Dodd M.ACTIVATION Trial InvestigatorsACTIVATION (PercutAneous Coronary inTervention prIor to transcatheter aortic VAlve implantaTION): a randomized clinical trial.JACC Cardiovasc Interv2021;14:1965-74

[24] Søndergaard L,Reardon MJ.SURTAVI Trial InvestigatorsComparison of a complete percutaneous versus surgical approach to aortic valve replacement and revascularization in patients at intermediate surgical risk: results from the randomized SURTAVI trial.Circulation2019;

[25] Barbanti M,Capodanno D.OBSERVANT Research GroupTranscatheter or surgical treatment of severe aortic stenosis and coronary artery disease: a comparative analysis from the Italian OBSERVANT study.Int J Cardiol2018;270:102-6

[26] Kotronias RA,Scarsini R.Transcatheter aortic valve replacement and percutaneous coronary intervention versus surgical aortic valve replacement and coronary artery bypass grafting in patients with severe aortic stenosis and concomitant coronary artery disease: a systematic review and meta-analysis.Catheter Cardiovasc Interv2020;96:1113-25

[27] Barbato E,Johnson NP.A prospective natural history study of coronary atherosclerosis using fractional flow reserve.J Am Coll Cardiol2016;68:2247-55

[28] van Nunen LX,Tonino PAL.Fractional flow reserve versus angiography for guidance of PCI in patients with multivessel coronary artery disease (FAME): 5-year follow-up of a randomised controlled trial.Lancet2015;386:1853-60

[29] Fearon WF,De Bruyne B.FAME 2 Trial InvestigatorsClinical outcomes and cost-effectiveness of fractional flow reserve-guided percutaneous coronary intervention in patients with stable coronary artery disease: three-year follow-up of the FAME 2 trial (fractional flow reserve versus angiography for multivessel evaluation).Circulation2018;137:480-7

[30] Knuuti J,Saraste A.ESC Scientific Document Group2019 ESC Guidelines for the diagnosis and management of chronic coronary syndromes.Eur Heart J2020;41:407-77

[31] Rajappan K,Dutka DP.Mechanisms of coronary microcirculatory dysfunction in patients with aortic stenosis and angiographically normal coronary arteries.Circulation2002;105:470-6

[32] Eberli FR,Schwitter J.Coronary reserve in patients with aortic valve disease before and after successful aortic valve replacement.Eur Heart J1991;12:127-38

[33] Stoller M,Zbinden R.Left ventricular afterload reduction by transcatheter aortic valve implantation in severe aortic stenosis and its prompt effects on comprehensive coronary haemodynamics.EuroIntervention2018;14:166-73

[34] Scarsini R,Di Gioia G.The influence of aortic valve obstruction on the hyperemic intracoronary physiology: difference between resting Pd/Pa and FFR in aortic stenosis.J Cardiovasc Transl Res2019;12:539-50

[35] Pesarini G,Zivelonghi C.Functional assessment of coronary artery disease in patients undergoing transcatheter aortic valve implantation: influence of pressure overload on the evaluation of lesions severity.Circ Cardiovasc Interv2016;9:e004088

[36] Lunardi M,Venturi G.Physiological versus angiographic guidance for myocardial revascularization in patients undergoing transcatheter aortic valve implantation.J Am Heart Assoc2019;8:e012618 PMCID:PMC6915256

[37] Ahmad Y,Cook C.Coronary hemodynamics in patients with severe aortic stenosis and coronary artery disease undergoing transcatheter aortic valve replacement: implications for clinical indices of coronary stenosis severity.JACC Cardiovasc Interv2018;11:2019-31 PMCID:PMC6197079

[38] Yamanaka F,Ochiai T.Instantaneous wave-free ratio for the assessment of intermediate coronary artery stenosis in patients with severe aortic valve stenosis: comparison with myocardial perfusion scintigraphy.JACC Cardiovasc Interv2018;11:2032-40

[39] Scarsini R,Venturi G.Correlation between intracoronary physiology and myocardial perfusion imaging in patients with severe aortic stenosis.Int J Cardiol2019;292:162-5

[40] Scarsini R,Lunardi M.Observations from a real-time, iFR-FFR "hybrid approach" in patients with severe aortic stenosis and coronary artery disease undergoing TAVI.Cardiovasc Revasc Med2018;19:355-9

[41] Goel SS,Tuzcu EM.Percutaneous coronary intervention in patients with severe aortic stenosis: implications for transcatheter aortic valve replacement.Circulation2012;125:1005-13

[42] Faroux L,Munoz-Garcia E.Procedural characteristics and late outcomes of percutaneous coronary intervention in the workup pre-TAVR.JACC Cardiovasc Interv2020;13:2601-13

[43] van Rosendael PJ,Kamperidis V.Timing of staged percutaneous coronary intervention before transcatheter aortic valve implantation.Am J Cardiol2015;115:1726-32

[44] Venturi G,Pesarini G.Contrast-induced acute kidney injury in patients undergoing TAVI compared with coronary interventions.J Am Heart Assoc2020;9:e017194 PMCID:PMC7660800

[45] Barbanti M,Costa G.Optimized screening of coronary artery disease with invasive coronary angiography and ad hoc percutaneous coronary intervention during transcatheter aortic valve replacement.Circ Cardiovasc Interv2017;10:e005234

[46] Ben-Dor I,Looser PM.Outcomes of concomitant percutaneous coronary intervention and balloon aortic valvuloplasty.Catheter Cardiovasc Interv2013;82:E835-41

[47] Daniec M,Dziewierz A.In-hospital and long-term outcomes of percutaneous balloon aortic valvuloplasty with concomitant percutaneous coronary intervention in patients with severe aortic stenosis.J Interv Cardiol2018;31:60-7

[48] Singh V,Inglessis-Azuaje I,O'Neill WW.The role of impella for hemodynamic support in patients with aortic stenosis.Curr Treat Options Cardiovasc Med2018;20:44

[49] Diaz Quintero L, Gajo E, Guerrero M, Feldman T, Levisay J. Balloon aortic valvuloplasty followed by impella®-assisted left main coronary artery percutaneous coronary intervention in patients with severe aortic stenosis as a bridge to transcatheter aortic valve replacement.Cardiovasc Revasc Med2021;22:16-21

[50] Nai Fovino L,Massussi M.Incidence and feasibility of coronary access after transcatheter aortic valve replacement.Catheter Cardiovasc Interv2020;96:E535-41

[51] Yudi MB,Tang GHL.Coronary angiography and percutaneous coronary intervention after transcatheter aortic valve replacement.J Am Coll Cardiol2018;71:1360-78

[52] Ribeiro HB,Makkar RR.Predictive factors, management, and clinical outcomes of coronary obstruction following transcatheter aortic valve implantation: insights from a large multicenter registry.J Am Coll Cardiol2013;62:1552-62

[53] Barbanti M,Picci A.Coronary cannulation after transcatheter aortic valve replacement: the RE-ACCESS study.JACC Cardiovasc Interv2020;13:2542-55

[54] Ochiai T,Yoon SH.Coronary access after TAVR.JACC Cardiovasc Interv2020;13:693-705

[55] Katsanos S,van der Kley F.Position of edwards SAPIEN transcatheter valve in the aortic root in relation with the coronary ostia: implications for percutaneous coronary interventions.Catheter Cardiovasc Interv2015;85:480-7

[56] Abdelghani M,Traboulsi H,Richardt G.Coronary access after TAVR with a self-expanding bioprosthesis: insights from computed tomography.JACC Cardiovasc Interv2020;13:709-22

[57] Rogers T,Weissman G.Feasibility of coronary access and aortic valve reintervention in low-risk TAVR patients.JACC Cardiovasc Interv2020;13:726-35

[58] Tang GHL,Fuchs A.Alignment of transcatheter aortic-valve neo-commissures (ALIGN TAVR): impact on final valve orientation and coronary artery overlap.JACC Cardiovasc Interv2020;13:1030-42

[59] Tagliari AP,Zimmermann JM.Transcatheter aortic valve neo-commissure alignment with the Portico system.EuroIntervention2021;17:e152-5

[60] Bieliauskas G,Bajoras V.Patient-specific implantation technique to obtain neo-commissural alignment with self-expanding transcatheter aortic valves.JACC Cardiovasc Interv2021;14:2097-108

[61] Tarantini G,Le Prince P.Coronary access and percutaneous coronary intervention up to 3 years after transcatheter aortic valve implantation with a balloon-expandable valve.Circ Cardiovasc Interv2020;13:e008972 PMCID:PMC7373469

[62] Khan M,Krishnamoorthy P.Coronary angiography and percutaneous coronary intervention after transcatheter aortic valve replacement with medtronic self-expanding prosthesis: insights from correlations with computer tomography.Int J Cardiol2020;317:18-24

[63] Bharadwaj AS,Sharma SK.Utility of the guideliner catheter for percutaneous coronary interventions in patients with prior transcatheter aortic valve replacement.Catheter Cardiovasc Interv2018;91:271-6

[64] Ochiai T,Flint N.Timing and outcomes of percutaneous coronary intervention in patients who underwent transcatheter aortic valve implantation.Am J Cardiol2020;125:1361-8

[65] Stefanini GG,Pivato CA.REVIVAL InvestigatorsUnplanned percutaneous coronary revascularization after TAVR: a multicenter international registry.JACC Cardiovasc Interv2021;14:198-207

[66] Faroux L,Vincent F.ST-segment elevation myocardial infarction following transcatheter aortic valve replacement.J Am Coll Cardiol2021;77:2187-99

[67] Kim WK,Ludwig S.Feasibility of coronary access in patients with acute coronary syndrome and previous TAVR.JACC Cardiovasc Interv2021;14:1578-90

[68] Nai Fovino L,Massussi M.Coronary angiography after transcatheter aortic valve replacement (TAVR) to evaluate the risk of coronary access impairment after TAVR-in-TAVR.J Am Heart Assoc2020;9:e016446 PMCID:PMC7670517

[69] Baumbach H,Wachter K.Transcatheter aortic valve replacement- management of patients with significant coronary artery disease undergoing aortic valve interventions: surgical compared to catheter-based approaches in hybrid procedures.BMC Cardiovasc Disord2019;19:108 PMCID:PMC6515676

[70] Ahad S,Rustenbach C.Concomitant therapy: off-pump coronary revascularization and transcatheter aortic valve implantation.Interact Cardiovasc Thorac Surg2017;25:12-7

[71] Mayr B,Erlebach M.Transcatheter aortic valve implantation and off-pump coronary artery bypass surgery: an effective hybrid procedure in selected patients.Interact Cardiovasc Thorac Surg2018;27:102-7

[72] Pirelli L,Scheinerman JS.Hybrid minimally invasive approach for combined obstructive coronary artery disease and severe aortic stenosis.Innovations (Phila)2020;15:131-7

[73] Santana O,Zamora C,Lamas GA.Staged percutaneous coronary intervention and minimally invasive valve surgery: results of a hybrid approach to concomitant coronary and valvular disease.J Thorac Cardiovasc Surg2012;144:634-9

[74] Santana O,Williams RF.Outcomes of a hybrid approach of percutaneous coronary intervention followed by minimally invasive aortic valve replacement.J Thorac Dis2017;9:S569-74 PMCID:PMC5505943

[75] Brinster DR,Rogers CD.Effectiveness of same day percutaneous coronary intervention followed by minimally invasive aortic valve replacement for aortic stenosis and moderate coronary disease ("hybrid approach").Am J Cardiol2006;98:1501-3

[76] George I,Kalesan B.Feasibility and early safety of single-stage hybrid coronary intervention and valvular cardiac surgery.Ann Thorac Surg2015;99:2032-7

[77] Zubarevich A,Szczechowicz M.Simultaneous transaortic transcatheter aortic valve implantation and off-pump coronary artery bypass: an effective hybrid approach.J Card Surg2021;36:1226-31